Manganese Encephalopathy among Ephedron Abusers-Case Reports

Journal of Neuroimaging

Volumn 25, Issue 5, 2015, Pages 832-835

  Janocha Litwin, Justyna ^a   Marianska, Katarzyna ^a   Serafinska, Sylwia ^a,b   Simon, Krzysztof ^a,b  

^a J Gromkowski Provincial Specialist Hospital   (Poland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

HIV infection; Manganese induced Parkinsonism; Poland

Indexed keywords

AMPHETAMINE; ANTINEOPLASTIC AGENT; CANNABIS; DIAMORPHINE; HEPATITIS B SURFACE ANTIBODY; LAMIVUDINE; LOPINAVIR; MANGANESE; METHADONE; METHCATHINONE; RITONAVIR; VIRUS RNA; ZIDOVUDINE; MONOMETHYLPROPION; PROPIOPHENONE DERIVATIVE;

ADULT; AMNESIA; ARTICLE; BEHAVIOR DISORDER; BODY EQUILIBRIUM; BRAIN DISEASE; CASE REPORT; CHEMOTHERAPY; DEMENTIA; DISEASES; DROWSINESS; DRUG ABUSE; EMERGENCY; EPHEDRONE INDUCED DEMENTIA; FOLLOW UP; GAIT DISORDER; HAND TREMOR; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HODGKIN DISEASE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOKINESIA; MALE; MANGANESE ENCEPHALOPATHY; MEDICAL HISTORY; MORPHINE ADDICTION; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT REFERRAL; PSYCHOMOTOR RETARDATION; REMISSION; SEPTICEMIA; SPEECH DISORDER; STUTTERING; WESTERN BLOTTING; YOUNG ADULT; CHEMICALLY INDUCED; MANGANESE POISONING; PATHOLOGY; SUBSTANCE-RELATED DISORDERS;

ADULT; BRAIN DISEASES; HUMANS; MALE; MANGANESE POISONING; PROPIOPHENONES; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 84939219637     PISSN: 10512284     EISSN: 15526569     Source Type: Journal    
DOI: 10.1111/jon.12173     Document Type: Article

References (10)

1. Levin OS. "Ephedron" encephalopathy. Zh Nevrol Psikhiatr Im S Korsakova 2005;105(7):12-20.
2. Gitler AG, Chesi A, Geddie ML, et al. Alfa-Synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity. Nat Genet 2009;41(3):308-315.
3. Sanotsky Y, Lesyk R, Fedoryshyn L, et al. Manganic encepahalopathy due to "ephedrone" abuse. Movement Disorders 2007;22(9):1337-1343.
4. Lucchini R, Apostoli P, Perrone C, et al. Long-term exposure to ''low levels' of manganese oxides and neurofunctional changes in ferroalloy workers. Neurotoxicity 1999;20:287-297.
5. Rkhard PR, Delavelle J, Du Pasquier R, et al. Chronic parkinsonism associated with cirrhosis. Arch Neurol 2002;60:521-528.
6. Cerosimo MG, Koller WC. The diagnosis of manganese-induced parkinsonism. Neutrotoxicology 2006;27(3):340-346.
7. Bal M, Monaghan T, Redmond J. Manganese toxicity with ephedrine abuse manifesting as parkinsonism: a case report. J Med Case Reports 2012;6:52:1-4.
8. Ustawa z dnia 20 marca 2009 roku o zmianie ustawy o przeciwdzialaniu narkomanii. Dz.U. 2009 nr 63 poz. 520
9. Myslicka M, Zuk M, Dziurkowski M: Uzalez˙nienie od efedronu-opis przypadku; Psychiatria Polska 2011, nr 1:79-85.
10. http://hyperreal.info/talk/metkatynon-faq-opis-syntezy-t24734.html